Scop: Multe paciente cu cancer mamar prezintă creştere ponderală pe parcursul administrării chimioterapiei sau al tratamentului antiestrogenic, ceea ce creşte riscurile de limfedem, metastază, recurenţă şi mortalitate de cauză general şi specific oncologică. Studiul de faţă îşi propune să evalueze eficienţa unei intervenţii nutriţionale şi kinetice în contracarearea obezităţii pacientelor cu cancer mamar. Pacienţi şi metodă: 165 paciente cu cancer mamar ER+/PR±/ HER2-aflate în tratament antiestrogenic au fost randomizate pentru a urma timp de 1 an, la domiciliu, fie o dietă bazată pe alimente natural bogate în proteine, calciu, probiotice şi prebiotice (D), fie dieta şi 4 minute de exerciţii fizice izometrice (D+Ex). Am măsurat greutatea (G), adipozitatea subcutanată (AS) şi adipozitatea viscerală (AV) cu un cântar cu impedanţă bioelectrică cu multifrecvenţe la 6 şi 12 luni şi am corelat rezultatele cu tipul de chimioterapie, intervenţie chirurgicală şi tratament antiestrogenic. 
Introduction
Breast cancer patients, who gain weight during treatment, have a higher risk of all cause and oncologic specific mortality, de novo carcinogenesis and recurrence. (1) Besides, overeating or eating regardless of physical hunger, which are the main weight gain causes -insulin and leptin resistance, dysbiosis and dyslipidemia -are potentially aggravated during breast cancer chemotherapy by sarcopenia. (2) In addition, studies prove that sarcopenic obesity which develops during chemotherapy, is present even 3 years after chemotherapy treatment. (3, 4) Sarcopenia is not the main cause of weight gain during breast cancer chemotherapy, but it is aggravated by the following, major weight gain causes:
• Induced menopause -which accentuates muscle protein catabolism, generating the decrease in active motor units and type II muscle fibres atrophy, (5) • Insulin resistance -generated by sedentariness or by overeating and causing triglycerides accumulation in miocytes as well as decreased sarcolemma GLUT4 expression, (6) • Dyslipidemia -either caused by the eating behaviour or by chemotherapy per segenerates leptin resistance manifested by a decreased ability to perceive satiety, (7) • Intestinal Dysbiosis -directly generated as a chemotherapy side effect -cause modified intestinal permeability (increased for improperly digested proteins and decreased for disaccharides) which induces bloating, cramps, constipation or diarrhea, that may disturb the eating behaviour and eventually lead to insulin resistance and weight gain. (8) These main weight gain causes are worsened by sarcopenia through basal metabolic rate decrease, and sustained by the eating behaviour and sedentariness of the patient, generating:
• An increased body fat percentage and insulin resistance in patients who do not overeat, (9) Or • An increased body fat percentage and increased insulin and leptin resistance, dysbiosis and dyslipidemia in patients with excessive carbohydrate consumption. (10) Compensating these etiological weight gain factors, can be hard during chemotherapy, because many patients feel ill, anddue to the fact that, besides studies proving exercise safety during treatment, many oncologists do not recommend physical exercise, neither during nor after the breast cancer treatment. (11) Nutritionally, both sarcopenia and overeating can be decreased by a high protein diet, through improvement of the muscle protein synthesis/ degradation ratio, through an improved insulin sensitivity and satiety, as well as by influencing the postprandial secretion of insulin, (2) ghrelin, (12) and the main satiety hormones: GLP-1, cholecystokinin and peptide Y. (13) Dyslipidemia and leptin resistance can be improved by a daily intake of foods, high in omega-3 fatty acids such as fish, cold pressed extra virgin olive oil, rapeseed oil or canola oil, avocado, and various raw seeds, almonds and nuts, and by avoiding soft drinks (high in colorants and high fructose corn syrup), fried food and any food with hydrogenated fats on the ingredients list.
Dysbiosis can also be ameliorated by a daily intake of foods high in prebiotics such as whole grain cereals, beans, lentils, fresh fruits and vegetables, and probiotics such as yoghurt, kephir and sour milk.
Probiotics also have antiproliferative effects on tissues with non-intestinal localization, like breast and prostate, improving estrogenic metabolism and inactivating carcinogenic substances. (14) Comparative studies between probiotic supplements and the one of fermented dairy foods prove that dairies have higher anticarcinogenic effects, because they also contain beneficial metabolites produced by probiotics during milk fermentation. (15) Fermented dairies also ensure a highly bioavailable calcium intake, important for the protective impact of calcium and vitamin D sensing receptors, key regulators of cell proliferation, differentiation and apoptosis. Studies prove, that a high calcium intake may associate with better breast cancer prognostics. (16) Also, a meta-analysis of 11 studies demonstrates that a high calcium intake decreases breast cancer risk by 19%, as decreasing this risk is extremely important in preventing recurrence or de novo carcinogenesis in breast cancer survivors. (17) Kinetically, the regular practice of physical exercise during breast cancer treatment sustains a better prognostic (18) . Resistance exercises are the most effective ones for treating both sarcopenia (19) and the other weight gain Intervention  Diet  Diet + exercises  Total  Sample size  Initial  83  82  165  6 months  64  71  135  12 months  40  41  81  Type of surgery  Mastectomy  58  62  120  Conservatory  25  20  45  Type of chemotherapy  A  28  20  48  NA  30  30  60  NA&A  13  25  38  no chemotherapy  12  7  19  Type of antiestrogenic medication  Aromatase inhibitors  44  48  92  Tamoxifen  39  34  73   Table 1 . Initial distribution of the patients causes (20) , but are difficult to do after breast cancer surgery without a physical therapist supervision. Whole body balance isometric exercises are not as effective as resistance exercises because they cannot counteract insulin resistance, leptin resistance, dyslipidemia or dysbiosis (21) . Nevertheless, they can prevent skeletal muscle loss (22) , they can be practiced even during days when the patient feels ill. Moreover, after learning the proper way to execute them, they can be safely done without monitoring, and they take very little time which is a major argument to convince most patients to easily accept to do them.
Isometric exercises have an anaerobic-like effect improving muscle protein turn-overtowards maintaining active skeletal muscle mass (23) . Finally, if we add these muscle protective effects to a high protein diet which is meant to counteract insulin and leptin resistance, dyslipdemia and dysbiosis we can achieve fat loss without muscle loss despite antiestrogenic medication administration.
As for the safety of breast cancer patients practicing physical exercises, one meta-analysis of 51 studies performed in the last 25 years proves that low and moderate intensity physical exercise is safe and beneficial (24) .
Method
This home-based study aims to answer three questions: A high protein diet based on foods naturally high in proteins, omega-3 fatty acids, calcium, pro-and prebiotics can improve body composition by increasing insulin and leptin sensitivity, ameliorating dysbiosis and counteracting skeletal muscle protein catabolism. Additionally, it can assist in recurrence prevention through a moderate intake of glucose.
Patients were given a table on which foods were classified as proteins, carbohydrates or fibres supplying sources and were taught to consume them at each meal. Toprevent sarcopenia and to counteract the Warburg effect (especially in patients during neoadjuvant chemotherapy) we decreased the recommended percentage of carbohydrate intake from the common 55-60% to only 40%. Protein intake was calculated to reach 1.5g/ kg body, which practically meant a 25-30 g protein intake per meal for most patients. Also, current scientific literature does not support a low-fat approach for ER+ breast cancer patients, thus we recommended a 25-30% fat intake from foods sources of omega-3 fatty acids (fish, olive oil, raw nuts and seeds) and medium chain triglycerides mainly from fermented dairy foods (yoghurt, sour milk and kephir).
To prevent anaemia, we instructed them to eat foods high in proteins and calcium such as yoghurt, sour milk and kephir, raw seeds and nutsat different meals than foods high in iron just like fish, chicken, eggs, beans, chickpeas and other lentils. To prevent dysbiosis we instructed them to vary the food they eat as much as possible from day to day, to avoid eating foods containing unpasteurized raw animal ingredients (like unpasteurized ice cream or mayonnaise, sauces, deli meats or cheese, smoked raw fish, canned fish or roe), and to eat at least two fermented dairies portions per day.
To improve eating behaviour, we explained the metabolic differences between eating when not hungry and eating when physically hungry and we asked patients to learn to recognize gastric hunger and to respect it by not eating when not feeling hungry and by eating within a maximum of 1 hour after feeling this way (25) .
To sustain an effective lipolysis, beta-oxidation and complete fatty acids catabolism for energy, when not hungry patients could only drink plain water when not feeling hungry and they were asked not to consume snacks, and other drinks. One coffee was allowed at the first meal of the day, and tea with other meals. However, they were not allowed in between meals due to caffeine and theine impact on insulin secretion. In addition, no soft drinks were allowed due to their impact on presynaptic dopamine re-transporters and on hypothalamic leptin sensitivity.
Also, to ensure a proper gastric emptying time, an interval of 2 hours' minimum was recommended between taking any meal and sleeping. And, to avoid phytoestrogen interaction with antiestrogenic treatments, we recommended the complete avoidance of plant supplements and we asked patients to only take vitamins and minerals at their oncologists' recommendation.
As for the isometric exercises, patients were taught how to perform 7 of them, one for each day of the week. All 7 exercises involved maintaining whole body balance for 1 minute, four times per day.
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Results were initially analysed using a Friedman Test, then Post hoc analysis with Wilcoxon signed-rank tests were conducted if Friedman Test was significant, with a Bonferroni correction, resulting in a significance level set at p < 0.017. Friedman Test and Wilcoxon signed-rank tests were conducted using the exact tests and for Wilcoxon signedrank tests one-tailed significance was used.
Results
The patients' 1-year results show that both D+Ex and D patients obtained statistically significant weight loss and fat loss, but D patients did not obtain statistical significant fat loss throughout the entire duration of the intervention. When comparing initial values with the ones measured at 12th months, D patients lost 3,3 kg, 3,2% BF and 1% visceral fat, while D+Ex patients lost 6,5 kg, 3,3% BF and 2% visceral fat ( Table 2 ).
The D+Ex patients had a significant loss of total body weight (χ Wilcoxon tests were used to follow up these findings, with a Bonferroni correction, resulting a .017 level of significance. The weight significantly changed from the start to 6 months (Z = -5.45, p = .000), from 6 months to 12 months (Z= -4.47, p = .000) and from start to 12 months (Z = -5.51, p = .000). The body fat percentage also changed significantly from the start to 6 months (Z = -4.50, p = .000), from 6 months to 12 months (Z= -3.56, p = .000) and from start to 12 months (Z = -5.16, p = .000). It was the same case with the visceral fat percentage, with a significant change from the start to 6 months (Z = -4.63, p = .000), from 6 months to 12 months (Z= -2.78, p = .002) and from start to 12 months (Z = -4.61, p = .000).
The results for the D patients show a significant loss of total body weight (χ The following up Wilcoxon tests show that only the weight loss was significant from start to 6 months (Z = -4.38, p = .000), from 6 months to 12 months (Z= -2.18, p = .014) and from start to 12 months (Z = -4.58, p = .000).
The body fat percentage did not significantly decrease from start to 6 months (Z = -2.02, p = .021) and it did decrease significantly from 6 months to 12 months (Z = -2.41, p = .008) and from start to 12 months (Z = -2.56, p = .005). The loss of visceral fat percentage was significant from start to 6 months (Z = -3.20, p= .001), and to 12 months (Z = -3.75, p = .000), but not from 6 months to 12 months (Z = -2.01, p = .029).
Correlating these patients' 1-year results with the type of surgery, we concluded that patients with mastectomy obtained statistically significant weight and fat loss, while patients with conservatory treatment obtained statistically significant results at the 12 th month weight and adiposity measurement only in the D+Ex intervention (Table 3) .
Patients with D+Ex intervention obtained (Table 4) . Patients on AI obtained statistically significant results for both weight and fat loss regardless of the intervention they were assigned to. And patients on Tamoxifen with the D intervention only lost weight, while those on the D+EX intervention lost weight and body and visceral fat (Table 5) .
Discussions
Many studies prove that high protein diets are effective in counteracting sarcopenia. Campbell et all questioned the recommended 0.8g/ kg per day dietary allowance for protein as inadequate for older people to maintain skeletal muscle (26) . Then, in 2007, he co-authored Leidy's study proving that higher protein intake preserves lean mass and satiety during weight loss interventions (27) . The patients in our study were also at risk for sarcopenia, thus we used a 1.5 g protein intake/ kg body weight per day.
Paddon-Jones et all proved that high protein diets may represent a viable intervention for individuals at risk of sarcopenia in their 2004 study, when they managed to maintain lean leg massin patientsduring 28 days bed rest. But they offset the catabolic response to prolonged inactivity with essential amino acids and carbohydrates supplemented to mixed meals offered every 5 h (28). We used foods naturally high in proteins and we instructed patients to eat only when hungry. Then, in 2009, he proposed a novel and specific dietary approach to prevent or sarcopenia, recommending clinicians to stress the importance of ingesting 25-30g of protein with each meal, a recommendation we also used in our study (29) .
Other studies using high protein diets in breast cancer patients found them effective but most used resistance exercise to counteract sarcopenia.To our knowledge, this is the first study to evaluate weight and body composition change in breast cancer patients on antiestrogenic medication using a 4' whole body isometric exercise protocol.
A 2002 study authored by DemarkWahnefried et all yielded promising results in preventing chemotherapy-induced weight and body composition changes among young women who received adjuvant chemotherapy for breast cancer (30) . They used a specialized program of strength training, aerobic activity and a healthful diet (≤20% fat; fruit, vegetable and calcium-rich).
In Denmark-Wahnefried's study more than half of the patients approached for the intervention refused to participate because the exercises where performed in hospital settings, which raised the recommendation that weight gain preventing interventions would be more effective with a home-based approach. Our study was a home-based study, but because the kinetic intervention was done at home without monitoring, we have no way of being sure if the patients did the exercises or not.
To determine the effectiveness of weight loss intervention for breast cancer survivors, Playdon et al performed a systematic review of 15 weight loss studies in breast cancer survivors in 2013 (31) . Successful interventions used dietary, physical activity, and behaviour modification components, yet there was insufficient evidence to identify the interventions that led to successful weight loss, or to determine the weight loss necessary to affect biomarkers linked to breast cancer prognosis. The main drawbacks of the studies in this systematic review were short duration, the small study sample sizes and lack of follow-up beyond a 6-monthperiod. Our study also has a small sample size, but we assessed patients at 12 months. Still we had a1-year dropout rate of almost 50%.
Based on the day to day clinical practice, we expected that patients with conservative surgery would have better results but -as a group -patients with conservative surgery did not validate our expectations. The studied oncology nutrition literature generally finds no correlation between the type of surgery and the patients ability and/or willingness to lose weight after breast cancer treatment. The better results of our patients with mastectomy either in D or in D+Ex intervention group were probably due to better individual adherence to dietary rules and not to the type of surgery per se.
Current literature supports both the fact that breast cancer patients gain weight during chemotherapy (32) that adjuvant administration of chemotherapy may lead to greater weight gain (33) and that longer administration of this type of treatment may have a more detrimental metabolic impact (34) . What our study proved is that nutrition interventions alone might not be sufficient to counteract sarcopenia during chemotherapy be it neoadjuvant, adjuvant or both and that a minimal exercise protocol should be practiced during this treatment.
The results of our patients are not in line with other studies that show that aromatase inhibitors have higher musculoskeletal side effects (35) as our patients on Tamoxifen only lost weight and not fat neither at 6 nor at the 12 moth measurements.
Finally, about the way we measured body composition, multi-frequency BIA measurements can be easily used to assess patients' weight and body composition in clinical settings when limiting biased results as much as possible by ensuring the hydration and feeding status of the patient at the time of the measurement, and by doing measurements in the same standard conditions (36) .
Conclusions
In conclusion, in ER+/PR±/HER2-luminal A and B breast cancer patients on antiestrogenic medication this 1-year diet intervention was effective in counteracting treatment associated weight gain, potentially improving long-term prognosis. And adding at least a minimal exercise protocol to oncology nutrition intervention is essential during chemotherapy and antiestrogenic treatment.
